Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: A propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry

International Journal of Hematology

Volumn 91, Issue 5, 2010, Pages 855-864

  Nagafuji, Koji ^a,u   Matsuo, Keitaro ^b   Teshima, Takanori ^c   Mori, Shin Ichiro ^d   Sakamaki, Hisashi ^e   Hidaka, Michihiro ^f   Ogawa, Hiroyasu ^g   Kodera, Yoshihisa ^h   Kanda, Yoshinobu ⁱ   Maruta, Atsuo ^j   Mori, Takehiko ^k   Yoshiba, Fumiaki ^l   Ichinohe, Tatsuo ^m   Kasai, Masanobu ⁿ   Takatsuka, Yoshifusa ^o   Kubo, Kohmei ^p   Sao, Hiroshi ^q   Atsuta, Yoshiko ^r   Suzuki, Ritsuro ^r   Yoshida, Takashi ^s   Tsuchida, Masahiro ^t   Harada, Mine ^a   more..

^a KYUSHU UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j KANAGAWA CANCER CENTER   (Japan)

^k KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l TOKAI UNIVERSITY   (Japan)

^m KYOTO UNIVERSITY   (Japan)

ⁿ NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^o IMAMURA BUN IN HOSPITAL   (Japan)

^p AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^q Meitetsu Hospital   (Japan)

^r NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^t Ibaraki Children's Hospital   (Japan)

^u KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Allogeneic; Bone marrow transplantation; Graft versus host disease; Peripheral blood stem cell transplantation

Indexed keywords

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CONVALESCENCE; DISEASE REGISTRY; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OVERALL SURVIVAL; RELAPSE; RISK ASSESSMENT; SIBLING; TREATMENT OUTCOME; ADOLESCENT; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; DONOR; GRAFT VS HOST DISEASE; IMMUNOLOGY; JAPAN; LEUKEMIA; MIDDLE AGED; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPENSITY SCORE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; JAPAN; LEUKEMIA; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPENSITY SCORE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SIBLINGS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

HLA ANTIGEN;

EID: 77954540858     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0581-1     Document Type: Article

References (39)

1. A Gratwohl H Baldomero B Horisberger C Schmid J Passweg A Urbano-Ispizua, et al. 2002 Current trends in hematopoietic stem cell transplantation in Europe Blood 100 7 2374 2386 10.1182/blood-2002-03-0675 1:CAS:528:DC%2BD38XnvVGis7k%3D 12239145
2. J Morton C Hutchins S Durrant 2001 Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells Blood 98 12 3186 3191 10.1182/blood.V98.12.3186 1:CAS:528: DC%2BD3MXovVSgsrg%3D 11719353
3. AC Vigorito WM Azevedo JF Marques AM Azevedo KA Eid FJ Aranha, et al. 1998 A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies Bone Marrow Transplant 22 12 1145 1151 10.1038/sj.bmt.1701510 1:STN:280:DyaK1M7htVSjtQ%3D%3D 9894716
4. S Couban DR Simpson MJ Barnett C Bredeson L Hubesch K Howson-Jan, et al. 2002 A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies Blood 100 5 1525 1531 10.1182/blood-2002-01-0048 1:CAS:528:DC%2BD38XmslyhsLk%3D 12176866 (Pubitemid 34925122)
5. N Schmitz M Beksac D Hasenclever A Bacigalupo T Ruutu A Nagler, et al. 2002 Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia Blood 100 3 761 767 10.1182/blood-2001-12- 0304 1:CAS:528:DC%2BD38XlvVCltrs%3D 12130483 (Pubitemid 34832598)
6. H Mahmoud O Fahmy A Kamel M Kamel A El-Haddad D El-Kadi 1999 Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 24 4 355 358 10.1038/sj.bmt.1701906 1:STN:280:DyaK1MzpvVWmtQ%3D%3D 10467322
7. D Blaise M Kuentz C Fortanier JH Bourhis N Milpied L Sutton, et al. 2000 Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle J Clin Oncol 18 3 537 546 1:STN:280: DC%2BD3c7itVyksA%3D%3D 10653869 (Pubitemid 30078535)
8. JJ Cornelissen B van der Holt EJ Petersen L Vindelov CA Russel M Hoglund, et al. 2003 A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies Exp Hematol 31 10 855 864 10.1016/S0301-472X(03)00195-4 1:CAS:528:DC%2BD3sXnvVOlsro%3D 14550800 (Pubitemid 37211369)
9. D Heldal G Tjonnfjord L Brinch D Albrechtsen T Egeland R Steen, et al. 2000 A randomised study of allogeneic transplantation with stem cells from blood or bone marrow Bone Marrow Transplant 25 11 1129 1136 10.1038/sj.bmt.1702422 1:STN:280:DC%2BD3czgvFGksg%3D%3D 10849524
10. R Powles J Mehta S Kulkarni J Treleaven B Millar J Marsden, et al. 2000 Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial (see comment) Lancet 355 9211 1231 1237 10.1016/S0140-6736(00)02090-0 1:STN:280:DC%2BD3c3jtFSktw%3D%3D 10770306
11. WI Bensinger PJ Martin B Storer R Clift SJ Forman R Negrin, et al. 2001 Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers (see comment) N Engl J Med 344 3 175 181 10.1056/NEJM200101183440303 1:STN:280: DC%2BD3M7ksVWisQ%3D%3D 11172139 (Pubitemid 32064138)
12. M Korbling P Anderlini 2001 Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 98 10 2900 2908 10.1182/blood.V98.10.2900 1:CAS:528:DC%2BD3MXosFynsrs%3D 11698269
13. WI Bensinger R Clift P Martin FR Appelbaum T Demirer T Gooley, et al. 1996 Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 88 7 2794 2800 1:STN:280:DyaK28vjslSlsA%3D%3D 8839878 (Pubitemid 26327536)
14. WI Bensinger HJ Deeg 2000 Blood or marrow? (comment) Lancet 355 9211 1199 1200 10.1016/S0140-6736(00)02080-8 1:STN:280:DC%2BD3c3jtFSltw%3D%3D 10770296
15. H Oh FR Loberiza Jr MJ Zhang O Ringden H Akiyama T Asai, et al. 2005 Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations Blood 105 4 1408 1416 10.1182/blood-2004-06-2385 1:CAS:528:DC%2BD2MXhsVCht70%3D 15486071 (Pubitemid 40223655)
16. Y Morishima Y Morishita M Tanimoto R Ohno H Saito K Horibe, et al. 1989 Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group Blood 74 6 2252 2256 1:STN:280:DyaK3c%2FivVOlsg%3D%3D 2804362
17. T Sasazuki T Juji Y Morishima N Kinukawa H Kashiwabara H Inoko, et al. 1998 Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program (see comment) N Engl J Med 339 17 1177 1185 10.1056/NEJM199810223391701 1:STN:280:DyaK1cvkt1yqsg%3D%3D 9780337 Erratum 340(5):402 (Pubitemid 28482126)
18. MM Joffe PR Rosenbaum 1999 Invited commentary: propensity scores Am J Epidemiol 150 4 327 333 1:STN:280:DyaK1MzotFKisw%3D%3D 10453808
19. TE Tanimoto T Yamaguchi Y Tanaka A Saito K Tajima T Karasuno, et al. 2004 Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients Br J Haematol 125 4 480 493 10.1111/j.1365-2141. 2004.04943.x 15142119 (Pubitemid 38916194)
20. D Przepiorka D Weisdorf P Martin HG Klingemann P Beatty J Hows, et al. 1995 1994 consensus conference on acute GVHD grading Bone Marrow Transplant 15 6 825 828 1:STN:280:DyaK28%2Fot1Ojtw%3D%3D 7581076
21. HM Shulman KM Sullivan PL Weiden GB McDonald GE Striker GE Sale, et al. 1980 Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 69 2 204 217 10.1016/0002-9343(80)90380-0 1:STN:280:DyaL3c3mtlSksg%3D%3D 6996481 (Pubitemid 10036817)
22. S Becker A Ichino 2002 Estimation of average treatment effects based on propensity score Stata J 2 358 377
23. E Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
24. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 3 163 170 1:STN:280:DyaF287ht1Wgug%3D%3D 5910392
25. T Gooley W Leisenring J Crowley B Storer 1999 Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stat Med 18 6 695 706 10.1002/(SICI)1097-0258(19990330)18:6<695:: AID-SIM60>3.0.CO;2-O 1:STN:280:DyaK1M3itVequw%3D%3D 10204198 (Pubitemid 29126745)
26. V Coviello M Boffess 2004 Cumulative incidence estimation in the presence of competing risks Stata J 4 103 112
27. Stem Cell Trialists' Collaborative G 2005 Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials J Clin Oncol 23 22 5074 5087 10.1200/JCO.2005.09.020 (Pubitemid 46224015)
28. N Schmitz M Eapen MM Horowitz MJ Zhang JP Klein JD Rizzo, et al. 2006 Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation Blood 108 13 4288 4290 10.1182/blood-2006-05-024042 1:CAS:528:DC%2BD28XhtlWqsrbO 16946302 (Pubitemid 44913306)
29. M Eapen MM Horowitz JP Klein RE Champlin FR Loberiza Jr O Ringden, et al. 2004 Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry (see comment) J Clin Oncol 22 24 4872 4880 10.1200/JCO.2004.02.189 15520055 (Pubitemid 46638610)
30. A Urbano-Ispizua 2007 Risk assessment in haematopoietic stem cell transplantation: stem cell source Baillieres Best Pract Res Clin Haematol 20 2 265 280
31. RE Champlin N Schmitz MM Horowitz B Chapuis R Chopra JJ Cornelissen, et al. 2000 Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT) Blood 95 12 3702 3709 1:CAS:528:DC%2BD3cXktFChsLk%3D 10845900
32. E Koca RE Champlin 2008 Peripheral blood progenitor cell or bone marrow transplantation: controversy remains Curr Opin Oncol 20 2 220 226 10.1097/CCO.0b013e3282f5100b 18300773 (Pubitemid 351317411)
33. Y Kanda K Izutsu H Hirai H Sakamaki T Iseki Y Kodera, et al. 2004 Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate Leukemia 18 5 1013 1019 10.1038/sj.leu.2403343 1:CAS:528: DC%2BD2cXjtlyitL4%3D 15029208 (Pubitemid 38714628)
34. C Cutler S Giri S Jeyapalan D Paniagua A Viswanathan JH Antin 2001 Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis (see comment) J Clin Oncol 19 16 3685 3691 1:STN:280:DC%2BD3MvlvV2rsA%3D%3D 11504750
35. PL Weiden N Flournoy ED Thomas R Prentice A Fefer CD Buckner, et al. 1979 Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts N Engl J Med 300 19 1068 1073 1:STN:280: DyaE1M7ls1Krsg%3D%3D 34792
36. PL Weiden KM Sullivan N Flournoy R Storb ED Thomas 1981 Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation N Engl J Med 304 25 1529 1533 1:STN:280:DyaL3M7pslGnuw%3D%3D 7015133
37. H Kolb 2008 Graft-versus-leukemia effects of transplantation and donor lymphocytes Blood 112 12 4371 4383 10.1182/blood-2008-03-077974 1:CAS:528:DC%2BD1cXhsVCltbzO 19029455
38. A Ferrant M Labopin F Frassoni HG Prentice JY Cahn D Blaise, et al. 1997 Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Blood 90 8 2931 2938 1:CAS:528:DyaK2sXms1Crsbs%3D 9376573
39. M Yanada K Matsuo N Emi T Naoe 2005 Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis Cancer 103 8 1652 1658 10.1002/cncr.20945 15742336 (Pubitemid 40490026)